September 24, 2021

In overweight and obese adults at high cardiovascular risk, once-daily subcutaneous liraglutide plus changes in diet and physical activity reduced visceral fat, a single-center phase 4 placebo-controlled trial showed. Vincent Fong, MD, was interviewed for his reaction to the study by Medscape.

September 22, 2021

Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed for a story posted by VICE on people who haven't gotten vaccinated because they haven't gotten COVID-19 yet. He says adopting the mindset that you’ll be OK and “natural immunity” will protect you, you’re not doing your part to protect yourself or others.

September 17, 2021

Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed by WLWT-TV for a story posted on MSN about the growing popularity of rapid tests for COVID-19. He said the accuracy of the tests is improving.

October 29, 2021

In a story produced by Spectrum News, Robert Shapiro, MD, professor in the Department of Pediatrics at the UC College of Medicine was quoted on the topic of how helping young people succeed helps build resilient communities.

October 29, 2021

The anti-depressant drug fluvoxamine is being looked at by researchers as a possible treatment for COVID-19. A recently released study showed the drug showed a reduced risk of hospitalization and death among COVID patients. Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed for a Health.com story on the study results.

November 10, 2021

With people wearing masks over the past 18 months or so to ward off COVID-19, the incidence of the common cold has been reduced during that time. However, as more people get vaccines and boosters, and mask mandates are eased in some instances, the common cold could be poised to make a comeback as we head into the fall and winter months. Giddy posted a primer on what causes the common cold and how to combat it and one of the expert sources they cited was Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.

November 10, 2021

UC researchers are taking part in a new nearly $2 million, multiyear study that will help develop a new generation of PPE, or personal protective equipment, for health care workers. UC researchers will work with teams from Iowa State University and the University of California-Davis to improve the design, function and safety of PPE, or personal protective equipment, the university said in a release this week. The study is part of a multi-institutional, four-year grant worth $1.8 million from the Centers for Disease Control and Prevention. The Cincinnati Business Courier published a story on the research.

November 5, 2021

Verywell Family posted an article featuring experts on whether or not pregnant people should get the COVID-19 booster shot. One of those was Heather Masters, MD, assistant professor in the Department of Obstetrics and Gynecology at the UC College of Medicine.

November 9, 2021

Spray on skin, called RECELL, is now approved for both adults and children, sparing them the unnecessary pain of dozens of skin grafts. UC Health says it’s the first in the region to use the technology made by Avita. WVXU published a story on the spray, quoting Julia Slater, MD, assistant professor in the Department of Surgery at the UC College of Medicine.

January 6, 2022

More and more people who contract COVID-19 are experiencing symptoms for an extended period of time. In a story on this produced by WVXU, Richard Becker, MD, professor and director, UC Heart, Lung and Vascular Institute and UC Division of Cardiovascular Health and Disease, who runs a long COVID clinic at UC Medical Center, said some patients are seeing symptoms last as long as a year and a half.